Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors - PubMed (original) (raw)
Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors
M Mohammadi et al. Science. 1997.
Abstract
A new class of protein tyrosine kinase inhibitors was identified that is based on an oxindole core (indolinones). Two compounds from this class inhibited the kinase activity of fibroblast growth factor receptor 1 (FGFR1) and showed differential specificity toward other receptor tyrosine kinases. Crystal structures of the tyrosine kinase domain of FGFR1 in complex with the two compounds were determined. The oxindole occupies the site in which the adenine of adenosine triphosphate binds, whereas the moieties that extend from the oxindole contact residues in the hinge region between the two kinase lobes. The more specific inhibitor of FGFR1 induces a conformational change in the nucleotide-binding loop. This structural information will facilitate the design of new inhibitors for use in the treatment of cancer and other diseases in which cell signaling by tyrosine kinases plays a crucial role in disease pathogenesis.
Similar articles
- SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors.
Laird AD, Vajkoczy P, Shawver LK, Thurnher A, Liang C, Mohammadi M, Schlessinger J, Ullrich A, Hubbard SR, Blake RA, Fong TA, Strawn LM, Sun L, Tang C, Hawtin R, Tang F, Shenoy N, Hirth KP, McMahon G, Cherrington. Laird AD, et al. Cancer Res. 2000 Aug 1;60(15):4152-60. Cancer Res. 2000. PMID: 10945623 - Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain.
Mohammadi M, Froum S, Hamby JM, Schroeder MC, Panek RL, Lu GH, Eliseenkova AV, Green D, Schlessinger J, Hubbard SR. Mohammadi M, et al. EMBO J. 1998 Oct 15;17(20):5896-904. doi: 10.1093/emboj/17.20.5896. EMBO J. 1998. PMID: 9774334 Free PMC article. - Development of a binding model to protein tyrosine kinases for substituted pyrido[2,3-d]pyrimidine inhibitors.
Trumpp-Kallmeyer S, Rubin JR, Humblet C, Hamby JM, Showalter HD. Trumpp-Kallmeyer S, et al. J Med Chem. 1998 May 21;41(11):1752-63. doi: 10.1021/jm970634p. J Med Chem. 1998. PMID: 9599227 - Inhibitors of protein tyrosine kinases.
Fry DW, Bridges AJ. Fry DW, et al. Curr Opin Biotechnol. 1995 Dec;6(6):662-7. doi: 10.1016/0958-1669(95)80109-x. Curr Opin Biotechnol. 1995. PMID: 8527837 Review. - Heparan sulfate fibroblast growth factor receptor complex: structure-function relationships.
McKeehan WL, Kan M. McKeehan WL, et al. Mol Reprod Dev. 1994 Sep;39(1):69-81; discusison 81-2. doi: 10.1002/mrd.1080390112. Mol Reprod Dev. 1994. PMID: 7999363 Review.
Cited by
- FGF signalling regulates chromatin organisation during neural differentiation via mechanisms that can be uncoupled from transcription.
Patel NS, Rhinn M, Semprich CI, Halley PA, Dollé P, Bickmore WA, Storey KG. Patel NS, et al. PLoS Genet. 2013;9(7):e1003614. doi: 10.1371/journal.pgen.1003614. Epub 2013 Jul 18. PLoS Genet. 2013. PMID: 23874217 Free PMC article. - Pinhead signaling regulates mesoderm heterogeneity via the FGF receptor-dependent pathway.
Ossipova O, Itoh K, Radu A, Ezan J, Sokol SY. Ossipova O, et al. Development. 2020 Sep 11;147(17):dev188094. doi: 10.1242/dev.188094. Development. 2020. PMID: 32859582 Free PMC article. - FGF signaling acts on different levels of mesoderm development within Spiralia.
Andrikou C, Hejnol A. Andrikou C, et al. Development. 2021 May 15;148(10):dev196089. doi: 10.1242/dev.196089. Epub 2021 May 17. Development. 2021. PMID: 33999997 Free PMC article. - Anti-Angiogenic Properties of BDDPM, a Bromophenol from Marine Red Alga Rhodomela confervoides, with Multi Receptor Tyrosine Kinase Inhibition Effects.
Wang S, Wang LJ, Jiang B, Wu N, Li X, Liu S, Luo J, Shi D. Wang S, et al. Int J Mol Sci. 2015 Jun 12;16(6):13548-60. doi: 10.3390/ijms160613548. Int J Mol Sci. 2015. PMID: 26075871 Free PMC article. - The synthetic inhibitor of fibroblast growth factor receptor PD166866 controls negatively the growth of tumor cells in culture.
Risuleo G, Ciacciarelli M, Castelli M, Galati G. Risuleo G, et al. J Exp Clin Cancer Res. 2009 Dec 11;28(1):151. doi: 10.1186/1756-9966-28-151. J Exp Clin Cancer Res. 2009. PMID: 20003343 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Molecular Biology Databases
Miscellaneous